Brown RE - Search Results

1

Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis.

Zhang PL, Pellitteri PK, Law A, Gilroy PA, Wood GC, Kennedy TL, Blasick TM, Lun M, Schuerch C 3rd, Brown RE. Zhang PL, et al. Among authors: brown re. Mod Pathol. 2005 Jul;18(7):924-32. doi: 10.1038/modpathol.3800372. Mod Pathol. 2005. PMID: 15920558 Free article.

2

Morphoproteomics and bortezomib/dexamethasone-induced response in relapsed acute lymphoblastic leukemia.

Brown RE, Bostrom B, Zhang PL. Brown RE, et al. Ann Clin Lab Sci. 2004 Spring;34(2):203-5. Ann Clin Lab Sci. 2004. PMID: 15228234

3

Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.

Zhang PL, Malek SK, Prichard JW, Lin F, Yahya TM, Schwartzman MS, Latsha RP, Skaletsky M, Norfolk ER, Brown RE, Hartle JE, Potdar S. Zhang PL, et al. Among authors: brown re. Ann Clin Lab Sci. 2004 Spring;34(2):209-13. Ann Clin Lab Sci. 2004. PMID: 15228236

4

Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas.

Lin F, Brown RE, Shen T, Yang XJ, Schuerch C. Lin F, et al. Among authors: brown re. Appl Immunohistochem Mol Morphol. 2004 Jun;12(2):153-9. doi: 10.1097/00129039-200406000-00010. Appl Immunohistochem Mol Morphol. 2004. PMID: 15354742

5

Morphoproteomic and pharmacoproteomic correlates in hormone-receptor-negative breast carcinoma cell lines.

Brown RE, Lun M, Prichard JW, Blasick TM, Zhang PL. Brown RE, et al. Ann Clin Lab Sci. 2004 Summer;34(3):251-62. Ann Clin Lab Sci. 2004. PMID: 15487699

6

Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy.

Zhang PL, Lun M, Siegelmann-Danieli N, Blasick TM, Brown RE. Zhang PL, et al. Among authors: brown re. Ann Clin Lab Sci. 2004 Summer;34(3):263-70. Ann Clin Lab Sci. 2004. PMID: 15487700

7

Acute cellular rejection predominated by monocytes is a severe form of rejection in human renal recipients with or without Campath-1H (alemtuzumab) induction therapy.

Zhang PL, Malek SK, Prichard JW, Lin F, Yahya TM, Schwartzman MS, Latsha RP, Norfolk ER, Blasick TM, Lun M, Brown RE, Hartle JE, Potdar S. Zhang PL, et al. Among authors: brown re. Am J Transplant. 2005 Mar;5(3):604-7. doi: 10.1111/j.1600-6143.2004.00712.x. Am J Transplant. 2005. PMID: 15707416 Free article.

8

Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.

Lun M, Zhang PL, Siegelmann-Danieli N, Blasick TM, Brown RE. Lun M, et al. Among authors: brown re. Ann Clin Lab Sci. 2005 Winter;35(1):15-24. Ann Clin Lab Sci. 2005. PMID: 15830705

9

Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB.

Lun M, Zhang PL, Pellitteri PK, Law A, Kennedy TL, Brown RE. Lun M, et al. Among authors: brown re. Ann Clin Lab Sci. 2005 Summer;35(3):251-8. Ann Clin Lab Sci. 2005. PMID: 16081580

10

Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.

Brown RE, Zhang PL, Lun M, Zhu S, Pellitteri PK, Riefkohl W, Law A, Wood GC, Kennedy TL. Brown RE, et al. Ann Clin Lab Sci. 2006 Summer;36(3):273-82. Ann Clin Lab Sci. 2006. PMID: 16951268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,035 results

Search Page

Filters